Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep 4;8(3):255-259.
doi: 10.1007/s13167-017-0110-x. eCollection 2017 Sep.

Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress

Illana Gozes  1
Affiliations
Review

Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress

Illana Gozes. EPMA J. .

Abstract

This short review looks at Alzheimer's disease (AD) diagnosis through my own point of view, going from imaging through cerebrospinal fluid to blood proteins. Over the last couple of years, we have published two papers targeted at Alzheimer's diagnosis. In one paper, we took an approach of selecting a specific target, namely, activity-dependent neuroprotective protein (ADNP), and our results tightened the association of ADNP blood expression with intelligence. In another paper, we took an unbiased approach of analysis of all genes expressed in lymphoblastoid cells lines and discovered changes in expression of the regulator of G-protein signaling 2 (RGS2) as a potential AD predictor. This review will assess our data in comparison to selected independent studies focusing on blood protein biomarkers as well as assessing saliva and urine samples with potential predictive value for AD. Furthermore, the review will provide directions for a combination of innovative markers, stratifying the population toward disease prevention and personalized medicine.

Keywords: Alzheimer’s disease (AD); Personalized medicine; Predictive; Preventive.

PubMed Disclaimer

Conflict of interest statement

Professor Illana Gozes serves as the Chief Scientific Officer of Coronis Neurosciences.

References

    1. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9:119–28. - PMC - PubMed
    1. Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer’s disease. Nature. 2009;461:916–922. doi: 10.1038/nature08538. - DOI - PMC - PubMed
    1. Snitz BE, Lopez OL, McDade E, Becker JT, Cohen AD, Price JC, et al. Amyloid-beta imaging in older adults presenting to a memory clinic with subjective cognitive decline: a pilot study. J Alzheimers Dis. 2015;48(Suppl 1):S151–9. - PMC - PubMed
    1. P.S. Insel, N. Mattsson, R.S. Mackin, M. Scholl, R.L. Nosheny, D. Tosun, M.C. Donohue, P.S. Aisen, W.J. Jagust, M.W. Weiner, and I. Alzheimer’s disease neuroimaging, accelerating rates of cognitive decline and imaging markers associated with beta-amyloid pathology. Neurology 86 (2016) 1887–96. - PMC - PubMed
    1. Gozes I. Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice. EPMA J. 2010;1:305–316. doi: 10.1007/s13167-010-0029-y. - DOI - PMC - PubMed

LinkOut - more resources